Cargando…

Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer—an east and west multicenter study

PURPOSE: To determine the indications for adjuvant chemotherapy (AC) in patients with stage IIa gastric cancer (T3N0M0 and T1N2M0) according to the 7th American Joint Committee on Cancer (AJCC). METHODS: A total of 1593 patients with T3N0M0 or T1N2M0 stage gastric cancer were identified from the Sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Ze-Ning, Desiderio, Jacopo, Chen, Qi-Yue, Zheng, Chao-Hui, Li, Ping, Xie, Jian-Wei, Wang, Jia-Bin, Lin, Jian-Xian, Lu, Jun, Cao, Long-Long, Lin, Mi, Tu, Ru-Hong, Lin, Ju-Li, Zheng, Hua-Long, Huang, Chang-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889451/ https://www.ncbi.nlm.nih.gov/pubmed/31791240 http://dx.doi.org/10.1186/s12876-019-1096-8

Ejemplares similares

Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
por: Huang, Jiao-Bao, et al.
Publicado: (2021)

Indication for and Effect of Adjuvant Chemotherapy for Stage IIa (T3N0M0) Colon Cancer
por: Jeon, Chul-Hyo, et al.
Publicado: (2019)

Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution
por: Lu, Jun, et al.
Publicado: (2019)

Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer
por: Zhai, Zhen, et al.
Publicado: (2020)

Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection
por: Li, Xiao-hui, et al.
Publicado: (2022)

Solid component proportion is an important predictor of tumor invasiveness in clinical stage T(1)N(0)M(0) (cT(1)N(0)M(0)) lung adenocarcinoma
por: Li, Meng, et al.
Publicado: (2018)

Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI
por: Li, Shihong, et al.
Publicado: (2017)

Comparison of T2N0M0 and T3aN0M0 in Predicting the Prognosis of Patients With Renal Cell Carcinoma
por: He, Xiaobo, et al.
Publicado: (2020)

Prognostic factors in the patients with T2N0M0 colorectal cancer
por: Xu, Bin, et al.
Publicado: (2016)

Impact of duration of adjuvant chemotherapy in radically resected patients with T4bN1-3M0/TxN3bM0 gastric cancer
por: Wang, Qi-Wei, et al.
Publicado: (2018)

Who are the real high-risk patients with pathological T2N0M0 non-small-cell lung cancer that can benefit from adjuvant chemotherapy?
por: Hou, X., et al.
Publicado: (2022)

The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy
por: Fu, Wen-Fen, et al.
Publicado: (2020)

Does Tumor Size Improve the Accuracy of Prognostic Predictions in Node-Negative Gastric Cancer (pT1-4aN0M0 Stage)?
por: Xu, Mu, et al.
Publicado: (2014)

Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0
por: Wu, Lei-Lei, et al.
Publicado: (2022)

Management of Clinical T1N0M0 Esophageal Cancer
por: Yang, Andrew J., et al.
Publicado: (2019)

Optimal Surgery Type and Adjuvant Therapy for T1N0M0 Lung Large Cell Neuroendocrine Carcinoma
por: Peng, Kunwei, et al.
Publicado: (2021)

Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study
por: Mei, Yu, et al.
Publicado: (2022)

Rethinking the 8th AJCC System: Is It Suitable for Patients Aged <55 Years With Stage T4N1M0 Follicular Variant of Papillary Thyroid Carcinoma to Be Placed in Stage I?
por: Long, Wei, et al.
Publicado: (2020)

Pathologic N(0) Status in Clinical T(1)N(0)M(0) Lung Adenocarcinoma is Predictable by the Solid Component Proportion with Quantitative CT Number Analysis
por: Li, Meng, et al.
Publicado: (2017)

Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients
por: Zhang, Zhi-Ling, et al.
Publicado: (2011)

Predicting aggressive outcome in T1N0M0 breast cancer
por: Kronqvist, P, et al.
Publicado: (2004)

Role of surgery in T4N0-3M0 esophageal cancer
por: Qi, Chen, et al.
Publicado: (2023)

Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system
por: Sun, Ying, et al.
Publicado: (2012)

A new scoring system to evaluate adjuvant chemotherapy for patients with T2N0M0 gastric cancer after D2 gastrectomy
por: Xu, Quan, et al.
Publicado: (2022)

Age and Racial Differences among PSA-Detected (AJCC Stage T1cN0M0) Prostate Cancer in the U.S.: A Population-Based Study of 70,345 Men
por: Zhang, Hong, et al.
Publicado: (2013)

Extramural extension as indicator for postoperative adjuvant chemotherapy in Stage IIA (pT3N0) colon cancer
por: Akagi, Yoshito, et al.
Publicado: (2013)

Safety and efficacy of ultrasound-guided thermal ablation in treating T1aN0M0 and T1bN0M0 papillary thyroid carcinoma: A meta-analysis
por: Wang, Mei-Huan, et al.
Publicado: (2022)

Prognostic factors of T2aN0M0 (T3‐4cmN0M0, stage IB) non‐small‐cell lung cancer after surgery: Single‐center real‐world research
por: Liu, Lei, et al.
Publicado: (2021)

Stereotactic ablative radiotherapy for inoperable T1‐2N0M0 small‐cell lung cancer
por: Tang, Hui, et al.
Publicado: (2022)

Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery vs surgery plus radiotherapy
por: Zeng, Ya, et al.
Publicado: (2019)

Reconsidering N component of cancer staging for T1-2N0-2M0 small-cell lung cancer: a retrospective study based on multicenter cohort
por: Wu, Lei-Lei, et al.
Publicado: (2023)

Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study
por: Wu, Lei-Lei, et al.
Publicado: (2020)

Impact of adjuvant chemotherapy on T1N0M0 breast cancer patients: a propensity score matching study based on SEER database and external cohort
por: Shen, Kaiwen, et al.
Publicado: (2022)

Adjuvant I-131 therapy for T0–3 N1b M0 differentiated thyroid cancer with many (≥ 5) positive nodes
por: Fortune, E. Charles, et al.
Publicado: (2022)

Nutritional and clinical outcomes of chemoradiotherapy for clinical T1N0M0 esophageal carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2019)

Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas
por: Ye, Bo, et al.
Publicado: (2014)

Tumor size is associated with adjuvant chemotherapy benefit in T1N0M0 triple-negative breast cancer: a multicenter and propensity score matched analysis
por: Wu, Chenghui, et al.
Publicado: (2023)

The efficacy of induction chemotherapy or adjuvant chemotherapy added to concurrent chemoradiotherapy in T3-4N0-1M0 nasopharyngeal carcinoma: a propensity score-matched analysis
por: Zhong, Qiulu, et al.
Publicado: (2023)

Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?
por: Peng, Ding, et al.
Publicado: (2017)

Prognostic validation and therapeutic decision‐making of the AJCC eighth pathological prognostic staging for T3N0 breast cancer after mastectomy
por: Wu, San‐Gang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lf9emsh860nh5ddcekgthuc3uq